Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Screening Intervals for Diabetic Retinopathy and Implications for Care
1Gloucestershire Retinal Research Group, Gloucestershire Hospitals NHS Foundation Trust, Office above Oakley Ward, Cheltenham General Hospital, Sandford Road, Cheltenham, GL53 7AN, UK. peter.scanlon@glos.nhs.uk.
Individuals with no diabetic retinopathy (DR) face a low risk of progression, suggesting less frequent screening may be safe. This review examines evidence for reducing annual screening for low-risk diabetic retinopathy patients.
Area of Science:
- Ophthalmology
- Diabetology
- Public Health
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss.
- Annual screening is standard for DR detection.
- Identifying lower-risk groups could optimize screening protocols.
Purpose of the Study:
- To review evidence supporting less frequent screening for low-risk diabetic retinopathy (DR) patients.
- To evaluate the safety of extending screening intervals beyond one year.
Main Methods:
- Systematic review of existing evidence.
- Analysis of progression rates in individuals with no DR.
- Examination of different screening methodologies (digital photography).
Main Results:
- Individuals with no DR exhibit a low risk of progression to sight-threatening DR over two years (event rate <5 per 1000 person-years).
- This low risk is consistent across various digital screening methods.
- Low risk is defined by absence of DR on consecutive screenings or combined with risk factors.
Conclusions:
- Less frequent screening may be safe for carefully selected low-risk diabetic retinopathy patients.
- Screening intervals can potentially be extended beyond annual checks.
- Further research may refine risk stratification for personalized DR screening.
Related Concept Videos
Preventive Healthcare Services
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...

